Diligence memo · auto-generated · as of July 2, 2026

Red Dragon Health Corp.

Red Dragon Health Corp. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Red Dragon Health Corp. operates in Pharmaceuticals, based in WILMINGTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Red Dragon Health Corp. has raised $6.3M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.3M on —.

Valuation (modeled)modeled

Provath models Red Dragon Health Corp. at approximately $13M (range $7.2M–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.10× the median modeled value of Series A Pharmaceuticals companies (418 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

Comparablesmixed

Capital scale ranks ahead of 46% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 21% of those peers.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.